Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti® in Knee Cartilage Defects

NAActive, not recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 16, 2020

Primary Completion Date

June 10, 2022

Study Completion Date

January 31, 2027

Conditions
Osteoarthritis, Knee
Interventions
DEVICE

MegaCarti®

MegaCarti® application after microfracture through athroscopic or incision surgery

PROCEDURE

Microfracture

Microfracture through athroscopic or incision surgery

Trial Locations (4)

10444

National Health Insurance Service Ilsan Hospital, Goyang-si

02841

Korea University Anam Hospital, Seoul

03722

Yonsei University Health System, Severance Hospital, Seoul

06273

Yonsei University Health System, Gangnam Severance Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

L&C Bio

INDUSTRY